Company Filing History:
Years Active: 2017
Title: Klemens Hogenauer: Innovator in Pharmaceutical Chemistry
Introduction
Klemens Hogenauer is a notable inventor based in Oberwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on specific chemical compounds.
Latest Patents
Hogenauer holds two patents, with his latest inventions focusing on dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives. These compounds are described by a specific formula and include pharmaceutically acceptable salts and solvates. They are particularly relevant for treating disorders or diseases mediated by the activity of PI3K enzymes.
Career Highlights
Klemens Hogenauer is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore and develop new pharmaceutical compounds that have the potential to address significant medical needs.
Collaborations
Hogenauer has collaborated with esteemed colleagues such as Giorgio Caravatti and Sylvie Chamoin. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Klemens Hogenauer's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to impact the treatment of diseases, showcasing the importance of innovation in healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.